Enteric Pathogens Articles & Analysis
4 news found
These could include direct or indirect contact, ingestion, and inhalation. “Preventing pathogens from entering healthcare altogether is not possible, since that’s where the infirm congregate for care. Fortunately, there are numerous tools and techniques to mitigate exposure risks to pathogens,” said Derrick A. Denis, Senior ...
MV Biotherapeutics SA (from now on “MV Bio”), a Swiss microbiome biotherapeutics company and Malcisbo AG (from now on “Malcisbo”), a Swiss company developing carbohydrate-based vaccines are proud to announce a collaboration after winning an Innosuisse grant. Malcisbo and MV Bio have previously signed a contract, which gives Malcisbo the exclusive right to use MV Bio ...
The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications: ApyraVax®is a technology platform for live attenuated oral vaccines eliciting protective mucosal responses against enteric pathogens. ...
MV BioTherapeutics participated for the first time to the international event Bio Digital 2020 presenting the company, the pipeline to over 50 companies. “We weren’t sure about the potential success when we applied to the Swiss Pavillon with the sponsoring of Innosuisse” confirms Dr. Fabio Grassi, founder and chairman. “The support we got from Switzerland Global ...